Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0127399 BIOSOURCED COMPOUND HAVING EPOXIDE FUNCTIONS, METHOD FOR THE SYNTHESIS OF SUCH A COMPOUND, AND USE THEREOF FOR...
A compound has at least one epoxide function which can be synthesized by an epoxidation reaction of a compound having at least one hydroxyl function obtained...
2018/0127398 SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-- ...
The present invention relates to a substantially crystalline and free solid state form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) ...
2018/0127397 PYRAZOLYL QUINOXALINE KINASE INHIBITORS
The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of...
2018/0127396 INHIBITORS OF RAS AND METHODS OF USE THEREOF
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): ##STR00001## or a...
2018/0127395 SUBSTITUTED BENZIMIDAZOLES AND BENZOPYRAZOLES AS CCR(4) ANTAGONISTS
Benzimidazole, benzopyrazole and benzotriazole compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic...
2018/0127394 TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS
The present invention provides compounds of Formula (I): ##STR00001## a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate...
2018/0127393 SERINE/THREONINE KINASE INHIBITORS
Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of...
2018/0127392 ECKOL DERIVATIVES, METHODS OF SYNTHESIS AND USES THEREOF
Provided herein are eckol derivatives, methods of synthesis thereof and pharmaceutical compositions thereof. In other embodiments, provided herein are methods...
2018/0127391 PROCESS FOR PREPARATION OF DAPAGLIFLOZIN
The present invention relates to a process for the preparation of amorphous dapagliflozin. The present invention relates to 2,3-butanediol solvate of...
2018/0127390 EPOXYCYCLOHEXANE DICARBOXYLIC ACID DIESTER, PLASTICIZER, STABILIZER AND RESIN COMPOSITION
The purpose of the present invention is to provide a novel compound which is useful as a plasticizer that has improved heat resistance and cold resistance,...
2018/0127389 Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors
The invention provides compounds represented by the general formula I ##STR00001## wherein the substituents are defined in the application. The compounds are...
2018/0127388 THERAPEUTIC COMPOUNDS
Compounds disclosed herein including compounds of formula I': ##STR00001## and salts thereof are provided. Pharmaceutical compositions comprising compounds...
2018/0127387 PROCESS FOR MAKING BENZOXAZINES
A synthesis process for making a benzoxazine compound containing at least one benzoxazine unit from aromatic amine containing at least one primary amino group,...
2018/0127386 METHODS USING HDAC11 INHIBITORS
The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for...
2018/0127385 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME
The present specification provides a hetero-cyclic compound and an organic light emitting device comprising the same.
2018/0127384 HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula...
2018/0127383 NOVEL CLASS OF QUINOLONE HETEROCYCLIC AROMATIC MOLECULES FOR CANCER TREATMENT
The invention is directed to new class of quinolone heterocyclic aromatic molecules (Renotinibs) and their use in the treatment of cancer, in particular,...
2018/0127382 METHOD FOR MANUFACTURING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND INTERMEDIATE OF SAME
An object of the present invention is to provide a method for industrially manufacturing a nitrogen-containing heterocyclic compound which shows excellent FLT3...
2018/0127381 NOVEL 6,7-DIHYDROPYRIDO[2,1-A]PHTHALAZIN-2-ONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION
The invention provides novel compounds having the general formula: ##STR00001## wherein R.sup.1 to R.sup.6 are as described herein, compositions including the...
2018/0127380 IMIDAZOLYL TRICYCLIC ENONES AS ANTIOXIDANT INFLAMMATION MODULATORS
Disclosed herein are compounds of the formula: (I), wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some...
2018/0127379 PYRIDYL ANALOGS OF 1-(2-CYANO-3,12-DIOXOOLEANA-1,9(11)DIEN-28-OYL) IMIDAZOLE
Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl) imidazole and pharmaceutical compositions containing the same are provided.
2018/0127378 TETRASUBSTITUTED ALKENE COMPOUNDS AND THEIR USE
Disclosed herein are compounds, or pharmaceutically acceptable salts thereof, and methods of using the compounds for treating breast cancer by administration...
2018/0127377 5-SUBSTITUTED INDAZOLE-3-CARBOXAMIDES AND PREPARATION AND USE THEREOF
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole...
2018/0127376 NOVEL CRYSTALLINE FORM OF ESLICARBAZEPINE
The present invention provides novel crystalline form L1 of eslicarbazepine characterized by diffraction peaks at 7.09, 10.03, 11.73, 14.12, 16.94, 18.03,...
2018/0127375 MORPHINAN DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
The present invention relates to compounds and their use as ligands for mu opioid receptors. Also included are methods for preparing the compounds and...
2018/0127374 BENZOMORPHAN COMPOUNDS AS OPIOID RECEPTORS MODULATORS
The present invention is directed to Benzomorphan Analog compounds of the Formula (I), Formula (IA), Formula (IB), Formula (IC), or Formula (ID) as shown...
2018/0127373 PROCESS FOR THE SYNTHESIS OF IVACAFTOR AND RELATED COMPOUNDS
The present patent discloses a novel one pot two-step process for the synthesis of ivacaftor and related compounds of [Formula (I)], wherein R.sup.1, R.sup.2,...
2018/0127372 NOVEL AMIDOHETEROARYL AROYL HYDRAZIDE ETHYNES
The present invention relates to novel amidoheteroaryl aroyl hydrazide ethynes as tyrosine kinase inhibitors, process of preparation thereof, and use of the...
2018/0127371 TERT-BUTYL N-[2-{4-[6-AMINO-5-(2,4-DIFLUOROBENZOYL)-2-OXOPYRIDIN-1(2H)-YL]- -3,5-...
The present invention provides a compound which is: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-diflu- ...
2018/0127370 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
2018/0127368 TRICYCLIC SULFONES AS ROR GAMMA MODULATORS
There are described ROR.gamma. modulators of the formula (I), ##STR00001## or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs...
2018/0127367 Pro-Neurogenic Compounds
This technology relates generally to compounds and methods for stimulating neurogenesis (e.g., post-natal neurogenesis, including post-natal hippocampal and...
2018/0127366 Tetrahydrocarbazole Inhibitors Of SIRT1 Receptors
Described are deuterium-substituted tetrahydrocarbazole compounds of Formulae I, II, or III which are inhibitors of sirtuin 1 (SIRT1). Also described are...
2018/0127365 C5, C6 SUBSTITUTED AND/OR FUSED OXINDOLES AS ANTI-CANCER AGENTS AND PROCESS FOR PREPARATION THEREOF
The present invention describes the C5,C6 Substituted and/or fused oxindole compounds useful as anti-cancer agents and process for preparation thereof....
2018/0127364 PYRROLIDINE COMPOUND
Compound (1) is useful as a catalyst since compound (III) can be obtained by reacting compound (I) with compound (II) in the presence of compound (I). ...
2018/0127363 LIQUID THIOETHER CARBOXYLIC ACID ESTERS
The present invention relates to a liquid thioether carboxylic acid ester, a process for the preparation of the liquid thioether carboxylic acid ester, an...
2018/0127362 COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES
The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present...
2018/0127361 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B
Inhibitors of HBV replication of Formula (I) ##STR00001## including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R.sub.1,...
2018/0127360 AMINO ACID BASED AMPHOTERIC SURFACTANT
Disclosed is a novel amino acid derived surfactant which is prepared by forming the salt of an alkylaminopropionic acid and a basic amino acid such as arginine...
2018/0127359 NITRITE SALTS OF 1,1-DIMETHYLBIGUANIDE, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE
Provided herein are nitrite salts of 1,1-dimethylbiguanide; and isotopic variants thereof; and pharmaceutically acceptable hydrates and solvates thereof. Also...
2018/0127358 ANTI-INFLAMMATORY DRUG AND USES THEREOF
An anti-inflammatory drug containing a G0/G1 switch 2 (G0S2) inhibitor as an active ingredient is useful as a novel anti-inflammatory drug.
2018/0127357 (2-AMINO-4-(ARYLAMINO)PHENYL) CARBAMATES
A compound, or pharmaceutically acceptable salt thereof, having a formula I of: ##STR00001## wherein R.sup.1 is H or optionally-substituted alkyl; R.sup.2...
2018/0127356 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS
The present invention relates to pyrimidine hydroxy amide compounds, the use of such compounds in the inhibition of HDAC6, and the use of such compounds in the...
2018/0127355 METHODS FOR MULTI-DOSE SYNTHESIS OF [F-18]FDDNP FOR CLINICAL SETTINGS
A method of manufacturing 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)-malon- onitrile ([F-18]FDDNP) utilizes a semi-automated module...
2018/0127354 A PROCESS FOR THE PREPARATION OF VERAPAMIL HYDROCHLORIDE
A process for the preparation of 5-(3,4-dimethoxyphenylethyl) methyl-amino-2-(3,4-dimethoxyphenyl)-2-isopropyl valeronitrile, which is known as Verapamil is...
2018/0127353 COMPOUNDS FOR USE AS THERAPEUTIC AGENTS AFFECTING P53 EXPRESSION AND/OR ACTIVITY
The present disclosure relates to compound (I) ##STR00001## wherein R1 and R2 independently represent a hydrogen atom, a (C.sub.1-C.sub.4)alkoxy group, a...
2018/0127352 SYNTHESIS OF NON-CYCLIC AMIDE AND THIOAMIDE BASED IONIC LIQUIDS
Non-cyclic amide or thioamide based ionic liquids and methods of making them are disclosed. The non-cyclic amide or thioamide based ionic liquid comprises a...
2018/0127351 METHOD FOR PURIFYING 1,4-DIAMINOBUTANE
A method for purifying 1,4-diaminobutane comprising the steps of: separating a second composition including carbonate salt of 1,4-diaminobutane from a first...
2018/0127350 PROCESS FOR PREPARING POLYOLS
The present invention relates to a process for preparing polyols. In particular, the present invention relates to the preparation, in a single step, of polyols...
2018/0127349 5-BROMO-2-(alpha-HYDROXYPENTYL)BENZOIC ACID SODIUM SALTS IN DIFFERENT CRYSTAL FORMS, AND PREPARATION METHOD THEREOF
The present invention discloses 5-bromo-2-(.alpha.-hydroxypentyl)benzoic acid sodium salt in different crystal forms and the preparation methods thereof, and...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.